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Contribution  
• What does this work add to what is already known?  
T2* weighted placental MRI provides antenatal information on placental function.  Short placental T2* 
relaxation time and increased hyperoxic BOLD response are both promising indicators of placental 
dysfunction.  
• What are the clinical implications of this work? 
T2* weighted placental MRI is fast to obtain and easy to analyse, which makes the method a promising 
antenatal test of placental dysfunction.  
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Introduction: 
Placental dysfunction is a common obstetric problem that complicates 5 – 10% of all pregnancies 
(1). It is a progressive condition, in which the fetal supply of oxygen and nutrients is insufficient to 
maintain normal fetal growth and organ development. The association between low birth weight 
and adverse neonatal outcome is well described (2). Moreover, there is evidence to support the 
hypothesis that common adult diseases such as metabolic syndrome and cardiovascular disease 
originate from abnormal fetal programming due to placental dysfunction – also known as Barker’s 
Hypothesis (3). Currently, there is no available treatment to improve placental function. However, 
correct antenatal identification of placental dysfunction leads to a four-fold improvement in the 
neonatal outcome, as it allows for timely delivery and thereby reduces the risk of irreversible fetal 
organ damage (4).  
Current antenatal screening of placental dysfunction focuses on fetal weight estimates and fetal 
and umbilical Doppler flow measurements. However, fetal size does not exactly reflect placental 
function. In addition, in late onset placental dysfunction, Doppler flows usually remain normal 
(5).Therefore, additional markers that directly reflect placental function have the potential to 
considerably improve the antenatal screening of placental dysfunction.  
There is increasing interest in placental MRI, due to its potential to detect placental dysfunction in 
vivo. In particular, T2* weighted MRI has proven to be a simple and useful method to assess 
placental health, either studying the quantitative T2* relaxation time or the relative change in the 
raw T2* weighted signal in response to a given challenge (the BOLD response). T2* depends 
primarily on oxygenation but also on other tissue factors, including villous density, inhomogeneities 
in the distribution of oxygenated blood, magnetic field inhomogeneities, and the presence of other 
paramagnetic molecules (6).  
This paper aims to explain the physiological basis for changes in T2* weighted signal intensity in 
the placenta. Previous literature on T2* weighted placental MR is reviewed and reference values 
are provided for 1.5 and 3 T. Practical guidance on how to optimize the T2* weighted scans is 
included, and the clinical potential of T2* weighted imaging as an antenatal test of placental 
dysfunction is outlined.
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Basic concepts of T2* weighted MRI 
T2* is the MRI transverse relaxation times which describes the time taken for the observed signal 
decay. It is a multifactorial, empirical measure that depends on many biological and physical 
features of the tissue. Specifically, in the placenta it depends on the more fundamental transverse 
relaxation time (T2) and volume fractions of the maternal and fetal blood, and of villous tissue, and 
on spatial variations in magnetic field across each voxel. The T2* of blood depends on the oxygen 
saturation of the blood, as well as other factors such as exchange between water and other 
molecules in the tissue, and water binding. Spatial variations in magnetic field can arise from a 
number of factors but primarily the heterogeneous distribution of deoxygenated blood. 
Oxyhaemoglobin and tissue both have similar slightly diamagnetic (negative) magnetic 
susceptibility whereas deoxyhaemoglobin has paramagnetic (positive) magnetic susceptibility. 
Variations in the magnetic susceptibility will lead to variations in the induced magnetic field within 
the tissue. Therefore, any spatial variations in the concentration of deoxyhaemoglobin across the 
placenta, for instance deoxygenated blood confined within fetal arterioles, or deoxygenated 
maternal blood draining from the placental intervillous space, could lead to a variation in magnetic 
field across the voxel.  
However there are other factors that may change the signal in the T2* weighted MRI scan. For 
instance most T2* weighted images retain some residual dependence on the longitudinal 
relaxation time (T1), and dissolved oxygen may the T1 of blood which could cause a further 
increase in the signal in the T2* weighted images (7,8). Biologically, infarcts can contain 
intracellular methaemoglobin (which is particularly paramagnetic) and fibrosis, which can also 
reduce T2 (9). In some cases incoherent movement of the blood during the echo time may reduce 
the signal intensity of the T2* weighted scans. Finally, large-scale magnetic field variations will 
affect T2*. Static effects can be minimized by shimming but maternal respiration can cause T2* to 
fluctuate. 
T2* forms the basis of the Blood Oxygen Level Dependent (BOLD) effect used in fMRI of the brain, 
in which changes in blood oxygenation and blood volume in response to neuronal activation lead to 
a change in the observed MRI signal. In contrast to the absolute T2* value, the BOLD effect is a 
relative measure, usually given as percentage of the baseline signal intensity. The T2* signal can 
be monitored over time to determine the relative change in T2* signal, or BOLD effect in response 
to interventions. However if T2* is measured quantitatively then normal reference values can be 
established to differentiate between normal and pathological placentas. 
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In utero the placenta consists of a large proportion of maternal blood. If the oxygen saturation of 
maternal blood is increased (by the mother breathing 100% oxygen) and assuming that there is no 
other physiological effects of the hyperoxic challenge, then the change in the placental T2* 
weighted signal (the BOLD effect) would be caused by the change in placental oxygenation.  
 
How to obtain placental T2* images 
There are several ways to obtain T2* weighted images of the placenta; fast gradient echo 
sequence (GE) or gradient-echo echo planar imaging (EPI) sequences, run in either single or 
multi-echo mode. GE sequences can achieve higher spatial resolution but take longer to acquire 
which makes them more sensitive to motion artefacts. For multi-Echo EPI data there is effectively 
no motion during the time required to acquire for each slice (<200ms), rendering it very robust to 
intra-slice motion, although the spatial resolution achievable is generally lower than for GE scans. 
At term the whole placenta can be scanned with EPI in a single breath hold using 
MultiBand/Simultaneous Multislice approaches. In principle GE-EPI will be affected by 
susceptibility artefacts in the abdomen, but the spherical nature of the pregnant uterus and the fluid 
filling the uterine and fetal cavities, make GE-EPI a very robust sequence for use in pregnancy 
even at 3T. It is preferable, however, to use image based B0 shimming for GE-EPI at 3T where 
available. 
We recommend using a trans-axial imaging plane with the field of view aligned with the scanner 
coordinates, to simplify planning. While coronal and sagital imaging planes are also possible the 
transaxial plane is commonly the most usefull, as the trans-axial imaging plane assures coverage 
of the main functional placental direction (maternal basal plate to fetal chorionic plate) within each 
image (without having to consider movement between slices). It is important that the field of view 
covers the whole of the abdomen to avoid artefacts from parallel imaging reconstruction 
techniques (e.g. SENSE artefacts). Similarly good fat suppression is required, for which the B0 
shim box must cover all the maternal subcutaneous fat.  
In addition, we suggest, that the subject lies in the left lateral position (10° - 20° tilt) mainly to avoid 
caval vein compression, as even minor changes in the maternal circulation may have a detectable 
impact on the placental T2* value. A recent paper by Humpries et al (10) suggests that maternal 
supine position in late pregnancy may reduce the flow in the inferior caval vein by 85%. The 
venous return in the azygos vein is compensatory increased however; the cardiac output is 
reduced by 16%. We also find that left lateral position makes it easier to image posterior placentas, 
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as we can often place the receiver coils closer to the placenta. If scanning supine, we recommend 
ensuring frequent contact with the mother, monitoring maternal blood pressure, heart rate and 
oxygen saturation using MR compatible monitoring equipment.  In addition splitting the scanning 
session into shorter sessions lasting no longer than 30-45 minutes will  ensure maternal comfort. 
Accurate recording of the position and tilt angle is important for analysis purposes, given the 
possibility that the maternal position may influence the physiology. 
Using this approach, a  baseline T2* weighted data set covering the entire placenta can be 
acquired within 5 minutes from entering the scanner room to leaving it again, which suggests that 
this simple measurement could be used for rapid monitoring of  placental health. 
We are often asked ‘what field strength should I use for placental imaging?’ 1.5T is the field 
strength used in most placental MRI studies reported so far, however 3T field strength is replacing 
the 1.5T systems in many centers and therefore it is likely, that 3T will be increasingly used in 
future placental MRI studies. As the field strength increases, the sensitivity of MRI increases and 
the sensitivity to the BOLD contrast increases super linearly. 3T images can provide exquisite 
detail on oxygenation in the human placenta but for a standard clinical test of placental 
dysfunction, 1.5T can give sufficient information. In addition, the intrinsically shorter T2* values at 
higher field strength can make it difficult to acquire data at sufficiently short echo times to provide 
sufficient sensitivity to changes in T2*. In addition, at 3T the RF fields can be very inhomogeneous 
leading to signal drop out in the center of the field of view particularly with the larger abdomen at 
late gestation, which can make it harder to image posterior placentas. Furthermore, higher field 
strength increases the risk of geometric distortions due to air-tissue interfaces, requiring special 
attention to B0 shimming especially if using high resolution EPI. While RF heating and acoustic 
noise are general safety concerns for fetal MRI, 3T magnets tends to have in general stronger 
gradient coils and hence higher acoustic output.  For our current state of knowledge, we 
recommend using Level 0 normal operating mode of RF or 2 W/kg, labelled by some vendors as 
‘low SAR’ or ’fetal MRI’, since the fetus has reduced heat loss mechanisms compared to the adult. 
Similarly, we recommend not using parallel transmit approaches unless the system vendor 
explicitly advises their use in pregnancy. For acoustic noise we recommend using reduced 
acoustic noise options available on the scanner.  
 
Data analysis 
The quantitative placental T2* relaxation time 
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For more detailed placental assessment it may be preferable to measure the absolute T2* 
relaxation time rather than just acquiring a T2* weighted image, since quantitative measurements 
make the results more comparable over time for longitudinal studies, between patients in cross 
sectional studies, and between scanners and sites for a given field strength in multicenter studies.  
We generally assume that T2* describes a mono-exponential decay. In that case in principle T2* 
can be estimated by a measurement at two echo times: the first being the shortest possible echo 
time and the second being at an echo time approximately equal to TE. The two echoes can either 
be collected from a single RF pulse (double echo sequence) or by repeating a single echo 
acquisition at two echo times which for the fast gradient echo sequence is the same sequence as 
used for IDEAL or DIXON fat/water scanning. T2* can then be estimated by calculating –dTe ln 
(S1/S2) where S1 and S2 are the signals from the first and second echo images respectively and 
dTe is the difference in the echo times of these two images.  
Alternatively multiple echoes can be fitted for T2*. Comparing the signal decay to a 
monoexponential function will highlight any systematic errors in the data e.g. from shimming errors 
or high noise floors due to Riccian noise. We therefore recommend sampling the signal decay of at 
least three echo times (with the longest echo time providing a signal that is above the noise floor). 
If the data is fitted for a mono-exponential decay then a weighted linear fit should be used and 
efforts should be made to eliminate data points influenced by the noise floor. Otherwise, the data 
could be fitted to a more complex function for instance to take account of the effects of through 
slice dephasing(11). Multi-echo sequences are automatically co-registered but will be more 
sensitive to motion during the acquisition, and repeated single echo acquisitions allow a wider 
range of echo times to be explored, which can provide better discrimination of the signal decay 
curve (Figure 1). 
Because of the heterogeneous nature of placental tissue and placental oxygenation, we 
recommend including as much placental tissue as possible in the region of interest (ROI) to 
improve the reproducibility of the T2* measurements. If possible a 3D volume should be obtained, 
or the T2* estimate should be based on an average of at least three slices spaced across the 
placenta. In each slice, the ROI should cover the entire placenta in a cross section perpendicular to 
the placental surface but amniotic fluid and large maternal vessels should be avoided by careful 
segmentation (Figure 2). In inhomogeneous appearing placentas, the segmentation should include 
all placental tissues, even regions with very low T2* values appearing almost homogeneously 
black. If necessary, segmentation can be assisted by checking the placental outline in T2 weighted 
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(fast spin echo) anatomical images (taking into account any movement between the acquisitions. 
The T2* measurement should be repeated at least 3 times with a minimal spacing of 3 minutes in 
order to identify artifacts related to uterine contractions (12). Extreme T2* values should be 
checked for susceptibility artifacts, movements artifacts (maternal and fetal) or contractions and 
excluded from the analysis. If both magnitude and phase maps are stored for T2* mapping data 
sets, then susceptibility weighted imaging and susceptibility mapping can be performed providing 
information that is more specific to oxygenation than T2* alone. 
 
Placental T2* mapping 
In addition to reporting the mean T2* relaxation time for the entire placental slice (2D) or placental 
organ (3D), a map of the different T2* value of each pixel can be created, to illustrate the T2* 
heterogeneity (Figure 6). Histogram distribution of the T2* values normalized by placental volume 
may provide a quantitative evaluation of the degree of tissue heterogeneity, which may be related 
to placental pathology (13,14). It also provides an opportunity to relate the T2* values to specific 
anatomic features. 
 
The placental BOLD effect 
If a time series of T2* weighted MRI scans is acquired across the placenta then the dynamic 
change in signal intensity can be estimated, this is generally known as the BOLD effect (ΔBOLD) 
(Figure 3). For instance experimental studies have investigated the placental response to maternal 
hyperoxia using the following equation to estimate the hyperoxic BOLD effect (15): 
ΔBOLD= (SHyperox – SNormox)/SNormox x 100% 
 
In order to achieve reliable estimates of the hyperoxic BOLD effect the dynamic scan should be 
continued until the placental response reaches the steady-state level. In the normal placenta the 
steady state level is reached within 5 minutes of maternal hyperoxia. However, in the dysfunctional 
placenta the time to steady state can be prolonged, sometimes even beyond 10 minutes. If the 
scan is stopped before the steady state level is reached, it may lead to an underestimation of the 
BOLD effect. Also, the T2* weighted scans are very sensitive to uterine contractions, which may 
also lead to an underestimation of the hyperoxic BOLD effect. Uterine contractions maybe 
identified by uterine movements in the dynamic scan or by the pregnant women. A recent 
publication suggests, that most contractions are subclinical, and therefore you cannot rely on 
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maternal reports alone (12).  Alternatively, if T2* is measured then the BOLD signal can be 
characterized by the absolute change in T2* (ΔT2*). 




A systematic search was performed in Pubmed/Medline (last updated November 8th, 2018) by 
combining the following terms “Placenta” AND “MRI” AND “T2* OR “BOLD”. This search yielded 
142 results. These papers were reviewed by title and abstract using the pre-specified inclusion 
criteria that required papers 1) were original studies and 2) included T2* weighted MR imaging of 
the placenta. There were no language restrictions, and we included both human and animal 
studies. The resulting 37 studies were then assessed by full text review, and a total number of 24 
studies fulfilled the inclusion criteria. Additional literature search by the reference lists of the 
included studies revealed no further studies for the review. The included papers are listed 
according to their date of publication and are separated into studies on the Placental BOLD effect 
(Table 1) and Placental T2* (Table 2). 
 
Dynamic T2* weighted placental MRI – Placental BOLD MRI  
Most human studies have investigated the changes in placental signal intensity during maternal 
hyperoxia (3 – 10 minutes of oxygen breathing) (15–21), and a single study investigates the effect 
of uterine contractions (21). In addition, three animal studies describe changes in placental signal 
intensity during maternal hypoxia (22), normoxic hypercapnia (23) and injection of vasoconstrictor 
(24). 
Human studies were performed at both 1.5T (12,15–18,21) and 3T (19,20) using single shot 
gradient echo EPI sequences. However, the specific echo-time (TE) and repetition-time (TR) 
varied between studies as presented in Table 1. 
  
Placental BOLD effects in experimental animal studies 
Experimental animal studies have investigated the correlation between acute changes in placental 
oxygenation and changes in placental BOLD signal intensity. In a sheep model maternal hypoxia 
lead to a mean reduction of the BOLD signal of a placental cotyledon by 29% (range 9-43%) (22). 
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In a rat model injection of Prostaglandin F2α, which is known to cause placental vasoconstriction, 
lead to a 10% reduction on placental BOLD signal intensity (24). Recently, a study conducted in 
mice investigated the effect of normoxic hypercapnia on the placental BOLD signal. A 44% 
reduction in placental BOLD signal was demonstrated, probably caused by placental hypo-
perfusion due to the vasoconstrictive effect of hypercapnia (23).  
 
The hyperoxic BOLD effect (ΔBOLD) in normal human pregnancies 
In normal human pregnancy the placental hyperoxic BOLD effect have been addressed in four 
studies (15,16,19,21). A significant increase in the placental signal intensity (ΔBOLD) was 
demonstrated during hyperoxia (15,16,21), and a positive correlation between ΔBOLD and 
gestational age was demonstrated (21). In normal pregnancies at term ΔBOLD was 20% (21).The 
findings are presented in Figure 3. 
 
The hyperoxic BOLD effect (ΔBOLD) in human pregnancies complicated by IUGR 
Three studies included IUGR pregnancies, and in these studies IUGR was defined by low 
birthweight (15,19) or low birthweight in combination with abnormal postnatal placental 
examination (21). Initially, a small study including four IUGR cases demonstrated inconsistent 
results regarding the hyperoxic BOLD effect (15). However, a larger case-control study including 
13 IUGR cases and 49 healthy controls demonstrated that placental ΔBOLD was significantly 
increased among IUGR cases (21), Figure 4. In addition, the study by Lou et al. demonstrates that 
in monochorionic twin pairs complicated by selective IUGR the time to reach hyperoxic steady 
state is prolonged in the smaller twin (19). 
 
Quantitative placental T2* relaxation time (Baseline T2*) 
The placental T2* relaxation time has been estimated in seven human studies (7,8,13,21,25–27) 
and six animal studies (14,28–32). The main purpose of these studies was to estimate the 
baselineT2* value in normal pregnancies and in pregnancies complicated by IUGR. In addition the 
hyperoxic placental T2* response (ΔT2*) has been addressed in five of these studies (16,23–
25,30). The studies are presented in Table 2. 
Five human studies were performed at 1.5T (7,8,21,25,27) and two human studies were performed 
at a 3T system (13,26) using a multi-echo gradient-recalled-echo (GRE) sequences. However, the 
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MRI protocols were different in regards to the number and values of the included echo-times as 
presented in Table 2. The protocol differences result in different accuracies in short and long T2* 
measurements. In all human studies the T2* value was obtained in large regions of interest (ROI) 
covering the entire placental cross section. Moreover, in the studies by Sinding et al. the T2* value 
was calculated as an average of three slices (21,25,27). The studies by Hutter et al. (13) and 
Armstrong et al. (26) are based on 3D placental models. In the remaining studies the T2* value 
was based on a single slice only (7,8). 
 
Quantitative placental T2* relaxation time in normal pregnancies (Baseline T2*) 
In normal pregnancies the association between the baseline T2* and gestational age has been 
investigated in a total of six studies; one study in a 3T MRI system (13) and five studies in a 1.5T 
MRI system (7,8,21,25–27). The largest studies have found a strong negative correlation between 
baseline T2* and gestational age (13,21,25,27). Ingram et al found a non-significant negative 
correlation (7), and a small study on 14 pregnant women failed to demonstrate such correlation (8).  
In normal pregnancies at term the placental baseline T2* was estimated to be 47-58 ms at 1.5T 
(7,8,25,27) and 25 ms at 3T (13) demonstrated in Figure 5 and Figure 6, respectively. The 
reproducibility of the baseline T2* measurements have been addressed by Sinding et al at 1.5T 
(25). In this study, the 95%-limits of agreement for within- and between-session variation for a 
single slice placental T2* measurement was -2.1±10.4ms and -0.6±22.6ms, respectively. In 
addition, this study demonstrated, that including large regions of interest and average of more 
slices improves the reproducibility of the T2* measurement. A recent publication by Hutter et al. 
have demonstrated that the within and between-session variation of T2* at 3T was 1.83+-2.42ms 
and 1.91+-21.60ms (13). 
Placental T2* mapping have demonstrated that the within placental heterogeneity of T2* is in the 
range of 10 – 200 ms, and the hyperintense areas are corresponding with the center of the 
cotyledons. In addition, the degree of heterogeneity is increased as pregnancy advances (13). The 
placental histogram is presented in Figure 6. 
 
Baseline T2* in pregnancies complicated by IUGR 
Four human studies included IUGR pregnancies (7,21,25,27). In these studies IUGR cases were 
defined by either low birth weight (25,27), a combination of low birth weight and abnormal umbilical 
Dopplers (7) or low birth weight and abnormal postnatal placental examination (21). Three studies 
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were designed as case-control studies (7,21,25). In each of these studies the baseline placental 
T2* value was significantly reduced in IUGR cases when compared to normal controls 
asdemonstrated in Figure 5. In a prospective cohort study, low placental T2* value was a strong 
predictor of low birth weight, and it performed significantly better than uterine artery Doppler flow 
measurements (27).  
 
The hyperoxic T2* response (ΔT2*) 
ΔT2* in response to maternal hyperoxia has been investigated in three human studies (7,8,21), 
which all found a significant increase in placental T2*. The largest study was conducted in 49 
normal pregnancies, and this study demonstrated a strong positive correlation between the ΔT2* 
and gestational age (21) (Figure 5). In the remaining two smaller studies Ingram et al. (7) (n=28) 
and Huen et al. (8) (n=14) failed to demonstrate such correlation. The increase in placental T2* 
during hyperoxia is supported by two experimental animal studies in rats (32) and mice (28).  
Two human studies included ΔT2* in IUGR pregnancies (7,21). In these studies IUGR was defined 
by either low BW and abnormal postpartum placental examination (21) or low BW and abnormal 
Doppler ultrasound findings (7). These studies found no significant difference between ΔT2* in 
IUGR pregnancies and normal controls. In animal studies there have been conflicting results 
concerning ΔT2* in IUGR cases. One experimental rat study by Chalouhi et al. reported that 
placenta ΔT2* in response to hyperoxia was reduced among IUGR cases (32), whereas a recent 
experimental study in mouse by Collinot et al reported that placental ΔT2* in response to hyperoxia 
was increased in IUGR (28).  
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Discussion  
Based on the literature review we conclude that T2* weighted placental MRI is a promising marker 
of placental dysfunction. Approximate reference values for the placenta at 1.5T and 3T, and tips 
and guidance on how to obtain placental baseline T2* values are presented in Table 3. 
It is a consistent finding, that placental dysfunction is associated with a lower baseline T2* value 
(7,14,21,25,28).  The underlying physiological explanation for the low T2* in placental dysfunction 
is not fully understood. It is well known that placental dysfunction is associated with impaired 
maternal placental perfusion due to defective transformation of the spiral arteries, which may lead 
to placental hypoxia (33). As T2* weighted MRI is particularly sensitive to the amount of 
deoxyhemoglobin present in the tissue, placental hypoxia may reduce T2*. However, in addition, 
changes in placental morphology such as altered villous density, deposits of fibrin and infarcts may 
also contribute to a lower T2* value. The latter is supported by a study by Wright et al 
demonstrating a significant positive correlation between placental T2 and morphological findings 
such as the relative density of fibrin deposition and villous volume (34). 
The majority of studies support a negative correlation between baseline T2* and gestational age 
(7,13,21,25). Direct measurements of the oxygenation in the intervillous space have demonstrated 
that oxygenation decreases as gestation advances (35), probably as a result of an increased 
extraction of oxygen from the intervillous space due to an increased feto-placental metabolic 
demand as pregnancy advances. In addition, normal physiological placental maturation is 
associated with morphological changes that may also alter the placental MRI signal intensity. Any 
comparison between groups should always include adjustment for gestational age at MRI. 
It has been demonstrated that the placenta has a heterogeneous appearance in T2* weighted 
images (15), and maps of T2* demonstrate that the heterogeneity increases with gestational age 
(13). The heterogeneity may reflect the oxygenation of the placental cotyledons. The cotyledon has 
a highly oxygenated center, where the maternal spiral arteries enters the intervillous space, and 
the oxygenation decreases toward to margins of the cotyledon where maternal blood drains back 
into the maternal venous circulation. Combining contrast enhanced MRI and placental T2* maps in 
non-human primates supports this hypothesis, as areas with a higher T2* value corresponds with 
the entrance of the spiral artery in the center of the cotyledon (31).  
Several studies have demonstrated that maternal hyperoxia increases the placental signal intensity 
in the T2* weighted image, also known as the hyperoxic BOLD effect (ΔBOLD) (15,16,18). The 
direct correlation between changes in placental signal intensity and changes in placental 
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oxygenation has been confirmed by an invasive experiment in a sheep model (22). In these 
experiments deoxyhemoglobin can be regarded an intrinsic contrast agent (31). At room air 
maternal arterial blood is already fully saturated, however hyperoxia leads to an increased 
saturation of the maternal venous blood in the intervillous space, which is generally accepted to be 
the main contributor of the hyperoxic BOLD effect. Fetal blood may also contribute to the hyperoxic 
BOLD effect, however this contribution is expected to be marginal as the proportion of fetal blood is 
markedly lower than the proportion of maternal blood in the placenta.  
In the dysfunctional placenta, ΔBOLD is increased when compared to the normal placenta (21). To 
understand this finding, one should remember that ΔBOLD is a relative measurement. Any 
increase in ΔBOLD may be due to an increase in absolute signal intensity and/or a reduced 
baseline absolute signal intensity. In the dysfunctional placenta, it has been demonstrated that the 
baseline T2* is markedly reduced when compared to normal controls (21). However, the change in 
absolute placental oxygenation, estimated by ΔT2*, did not differ between the normal and the 
dysfunctional placenta (21). This finding indicates, that the higher hyperoxic BOLD effect in 
dysfunctional placentas may simply reflect a lower T2* baseline value. Similarly, the positive 
correlation between ΔBOLD and gestational age in normal pregnancy may also be explained by a 
decreasing baseline T2*. These findings suggest, that as an initial clinical biomarker the fast and 
simple baseline T2* signal may provide sufficient information to discriminate between the normal 
and the dysfunctional placenta. 
Placental dysfunction is a main challenge in modern obstetrics and today it remains the leading 
cause of stillbirth (36). Baseline T2* may provide a valuable tool to differentiate between the 
constitutionally small fetus and the fetus suffering from placental dysfunction. A reliable marker of 
placental dysfunction in-vivo may increase the antenatal identification of placental dysfunction, 
which would allow for timely delivery and thereby reduce the number of stillbirths. Baseline T2* 
may provide early subclinical identification of placental dysfunction before abnormal fetal growth 
occurs. In addition, longitudinal studies based on baseline T2* offer an opportunity to evaluate the 
effect of treatment to improve placental function. An area of particular interest will be late onset 
placental dysfunction, which can present with appropriately grown fetuses and normal umbilical 
Doppler, so that the dysfunction often remains undetected. Other MRI markers of placental 
function such as baseline T1, T2 and diffusion weighted MRI still needs to be properly evaluated, 
since a combination of different MRI markers may further improve the antenatal detection of 
placental dysfunction. 
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Conclusion 
This review provides approximate reference values on 1.5T and 3T and useful guidance on how to 
obtain and analyze T2* placental values. Based on the previous literature, placental T2* is a 
promising marker to discriminate between the normal and dysfunctional placenta in-vivo. Initial 
studies suggest, that Placental T2* is a highly reproducible measurement with a great clinical 
potential. As the value of T2* obtained depends on the exact pulse sequence used pooling of 
results to provide clear guidelines for a specific T2* cutoff value is difficult at this stage. Future 
multicenter trials with a consistent MRI protocol performed at specific gestational ages in clinically 
well-defined population should be the next step to determine the clinical potential of T2* weighted 
placental MRI.  
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Figure legends 
 
Figure 1 Mean signal intensity (S) of the placental ROI at 16 different echo times (TE), with some 
corresponding MR images. The T2* decay curve was obtain using a non-linear square fitting 
algorithm. (Reprinted from Ref (25)) 
 
Figure 2 T2* weighted MR image (1.5 T) demonstrating the placental image plane . ROI should 
cover the entire placental area. (Reprinted from Ref (21)) 
 
Figure 3 The hyperoxic BOLD response in the normal placenta at 1.5T. Image at top: The visual 
placental changes during maternal hyperoxia; Figure A (normoxia) and Figure B (hyperoxia). 
Image at bottom: Changes in the normalized placental signal intensity (ΔBOLD) during maternal 
hyperoxia. ROI covers the entire placental area, and the colors refers to three different placental 
slices within the same placenta. (Reprinted from Ref (15)) 
 
Figure 4 The hyperoxic BOLD response (ΔBOLD) in relation to gestational age at MRI in normal 
pregnancies (open circles) and pregnancies complicated by fetal growth restriction (dark circles). 
The black lines indicate the association between ΔBOLD and gestational age in normal pregnancy 
(mean, 95% prediction interval). (Reprinted from Ref (21)) 
 
Figure 5 T2* weighted placental MRI at 1.5T in normal pregnancies and pregnancies complicated 
by placental dysfunction.  
Top: T2* weighted MR placental images (white arrow) in normal pregnancies and four cases of 
placental dysfunction. The dysfunction placenta appears markedly darker than normal placentas in 
the MR images. (Reprinted from Ref (25)) 
Bottom: The association between placental T2* measurements and gestational age in normal 
pregnancies (open circles) and pregnancies complicated by placental dysfunction (dark circles). 
Black lines indicates the least square fit of normal pregnancies; mean and 95% prediction interval. 
Left: Baseline placental T2*. Middle: Hyperoxic placental T2*. Right: The hyperoxic change in T2* 
value (ΔT2*). (Reprinted from Ref (21)) 
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Figure 6 T2* weighted placental MRI at 3T in normal pregnancies and in two cases of 
preeclampsia (PE). 
Top: T2* maps of coronal placental planes in two normal pregnancies (A) and two cases of PE (B). 
The blue lines illustrates the perceived lobules delineation. 
Bottom: A: The mean placental T2* value in relation to gestational age at MRI (GA). Normal 
pregnancies (blue crosses) and PE cases (red circles).B: T2* histogram normalized by placental 
volume. Color coded by gestational age at MRI. Dotted lines indicate the PE cases. (Reprinted 
from Ref (13)) 
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FGR:
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Case report s Natural occurring IUGR
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Table 3: Guidance on how to obtain placenta baseline T2* values
Approximate reference values for 
Placenta T2* at 40w
47-58 ms (1.5T System)
25ms (3T System)
Approximate reference values for 
Placenta T2* at 20w
150 ms (1.5T System)
90 ms (3T System)
Correlation with gestational age Negative  
Placental T2* value in IUGR cases Decreased
Approximate reference values for  
hyperoxic ΔBOLD at 20w
5% (1.5T System)
Approximate reference values for 
hyperoxic ΔBOLD at 40w
20% (1.5T System)
Correlation with gestational age Positive
Hyperoxic ΔBOLD in IUGR cases Increased
Tips for the MRI protocol  3-4 echo times, spread across the range of 
interest are sufficient for a mono-
exponential fit
 Image-based shimming is recommended 
for 3T if using EPI and/or high image 
resolution
Practical guidance  Left lateral position (10-20° tilt)
 Axial scan, cross-sectional placental 
images 
 Repeat measurement to identify artifacts
 For patient comfort max. scan-time is 30 
minutes
Tips for image analysis  Placental ROI as large as possible, but 
avoiding maternal vessels and amniotic 
fluid
 3D volume coverage when achievable, or 
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 Adjust for differences in GA at MRI
 Screen for effects of contractions (change 
in uterus size, decrease in T2*) and 
exclude this data
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